DK0751780T3 - Fremgangsmåder til isolering af CD1-fremviste antigener, vacciner, som omfatter CD1-fremviste antigener, og cellelinier til anvendelse i nævnte fremgangsmåder - Google Patents

Fremgangsmåder til isolering af CD1-fremviste antigener, vacciner, som omfatter CD1-fremviste antigener, og cellelinier til anvendelse i nævnte fremgangsmåder

Info

Publication number
DK0751780T3
DK0751780T3 DK94920784T DK94920784T DK0751780T3 DK 0751780 T3 DK0751780 T3 DK 0751780T3 DK 94920784 T DK94920784 T DK 94920784T DK 94920784 T DK94920784 T DK 94920784T DK 0751780 T3 DK0751780 T3 DK 0751780T3
Authority
DK
Denmark
Prior art keywords
methods
antigens
presented
isolating
cell lines
Prior art date
Application number
DK94920784T
Other languages
Danish (da)
English (en)
Inventor
Steven A Porcelli
Michael B Brenner
Evan Beckman
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Application granted granted Critical
Publication of DK0751780T3 publication Critical patent/DK0751780T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK94920784T 1993-06-21 1994-06-21 Fremgangsmåder til isolering af CD1-fremviste antigener, vacciner, som omfatter CD1-fremviste antigener, og cellelinier til anvendelse i nævnte fremgangsmåder DK0751780T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8007293A 1993-06-21 1993-06-21
PCT/US1994/006991 WO1995000163A1 (en) 1993-06-21 1994-06-21 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods

Publications (1)

Publication Number Publication Date
DK0751780T3 true DK0751780T3 (da) 2003-10-13

Family

ID=22155084

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94920784T DK0751780T3 (da) 1993-06-21 1994-06-21 Fremgangsmåder til isolering af CD1-fremviste antigener, vacciner, som omfatter CD1-fremviste antigener, og cellelinier til anvendelse i nævnte fremgangsmåder

Country Status (8)

Country Link
EP (1) EP0751780B1 (de)
JP (2) JPH08511939A (de)
AT (1) ATE248602T1 (de)
CA (1) CA2165786A1 (de)
DE (1) DE69433115T2 (de)
DK (1) DK0751780T3 (de)
ES (1) ES2201078T3 (de)
WO (1) WO1995000163A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6238676B1 (en) 1992-12-10 2001-05-29 Brigham And Women's Hospital Presentation of hydrophobic antigens to T-cells by CD1 molecules
US7063844B2 (en) 1992-12-10 2006-06-20 The Brigham And Women's Hospital, Inc. Presentation of hydrophobic antigens to T-cells by CD1 molecules
NZ283784A (en) 1994-04-14 1998-08-26 Adcock Ingram Ltd Diagnostic assay for mycobacterium and intracellular antigen
CA2202680A1 (en) * 1994-10-13 1996-04-25 Robert L. Modlin Presentation of hydrophobic antigens to t-cells by cd1 molecules
AU720288B2 (en) * 1995-02-22 2000-05-25 Adcock Ingram Limited A method for the isolation and purification of lipid cell-wall components
CA2243235C (en) * 1996-01-17 2010-08-10 Imperial College Innovations Limited Immunotherapy using cytotoxic t lymphocytes (ctl)
WO1998039025A2 (en) 1997-03-03 1998-09-11 Adcock Ingram Limited A composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the prevention, treatment and diagnosis of disease
EP1372668B1 (de) 2001-03-26 2011-12-07 Dana-Farber Cancer Institute, Inc. Verfahren zur abschwächung von reaktionen auf hautreizende mittel
WO2004093903A2 (en) * 2003-04-18 2004-11-04 The Brigham And Women's Hospital, Inc. Methods and compositions for immunomodulation using cd1 antigens
WO2006060117A2 (en) 2004-11-02 2006-06-08 The Board Of Trustees Of The Leland Stanford Junior University Methods for inhibition of nkt cells
EP2047860A1 (de) * 2007-10-12 2009-04-15 Centre National De La Recherche Scientifique (Cnrs) Pharmazeutische Zusammensetzungen mit Actinomycet-Glycerin-Acyl-Derivat-Antigenen, Verfahren zu deren Extraktion und ihre Verwendung gegen Tuberkulose
US10501541B2 (en) 2015-01-27 2019-12-10 Lava Therapeutics B.V. Single domain antibodies targeting CD1d
AU2019344300A1 (en) 2018-09-19 2021-04-22 LAVA Therapeutics N.V. Dual acting CD1D immunoglobulin

Also Published As

Publication number Publication date
DE69433115D1 (de) 2003-10-09
EP0751780B1 (de) 2003-09-03
DE69433115T2 (de) 2004-04-01
CA2165786A1 (en) 1995-01-05
JP2006104206A (ja) 2006-04-20
WO1995000163A1 (en) 1995-01-05
ATE248602T1 (de) 2003-09-15
EP0751780A1 (de) 1997-01-08
EP0751780A4 (de) 1997-12-10
ES2201078T3 (es) 2004-03-16
JPH08511939A (ja) 1996-12-17

Similar Documents

Publication Publication Date Title
DK0751780T3 (da) Fremgangsmåder til isolering af CD1-fremviste antigener, vacciner, som omfatter CD1-fremviste antigener, og cellelinier til anvendelse i nævnte fremgangsmåder
Bingham III et al. Periodontal disease and rheumatoid arthritis: the evidence accumulates for complex pathobiologic interactions
DK0941478T3 (da) Assaymetode for peptidspecifikke T-celler
DE69802191D1 (de) Festphase nukleinsäure-isolierung
DE69430365D1 (de) Isolierung fötaler erythrozyten
DE69434942D1 (de) Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben
MX9801687A (es) Compuestos y metodos para el diagnostico de tuberculosis.
ATE543098T1 (de) Identifizierung und isolierung somatischer stammzellen und verwendungen davon
ES2060621T3 (es) Anticuerpos anti-sustancia fr-900506 y metodo de inmunoensayo enzimatico altamente sensible.
Buchanan et al. Activation of the cell wall degrading protease, lysin, during sexual signalling in Chlamydomonas: the enzyme is stored as an inactive, higher relative molecular mass precursor in the periplasm.
DK1144447T3 (da) Dianostisk tuberkulosetest
TR199501326A2 (tr) Otoimmün hastaliklarin immünoterapilerinde kullanilmak üzere otoantijenden üretilen yeni peptidler.
KR950008537A (ko) 엡스타인 바 비루스(ebv)에 대한 항체의 검출용 진단제
DK0755517T3 (da) Fremgangsmåde til detektion af tilstedeværelse af en Mycobacterium-art og et kit og antistoffer til anvendelse i denne
WO1996012190A3 (en) Presentation of hydrophobic antigens to t-cells by cd1 molecules
ES8705635A1 (es) Procedimiento para la deteccion de la presencia de una aler-gia y para la deteccion especifica del alergeno responsable de la alergia
Delgado et al. Evaluation of an enzyme-linked immunosorbent assay for the detection of sheep infected and vaccinated with Brucella melitensis
ES8604693A1 (es) Un metodo para detectar un anticuerpo o un antigeno contenido en una muestra de fluido de origen biologico.
ES2308850T3 (es) Anticuerpos para antigenos de celulas de langerhans de mamiferos y sus usos.
Sandeman et al. Characterization of sheep antibodies involved in precipitate formation with surface antigens of Fasciola hepatica in vitro
ATE115632T1 (de) Verfahren zur in-vitro-analyse von metallinduzierten allergien.
NO953067L (no) Ekspresjon av beskyttende antigener
Engelkens et al. The influence of different sera on the in vitro immobilisation of Percoll purified Treponema pallidum, Nichols strain.
Kim et al. Characterization of a helper T cell epitope recognized by mice of a low responder major histocompatibility type
Simon An award for cell biology